Structures by: Pan Y.
Total: 408
Cl3Cu3H6O6Sm
Cl3Cu3H6O6Sm
Dalton Trans. (2017)
a=6.8227(5)Å b=6.8227(5)Å c=5.6249(5)Å
α=90° β=90° γ=120°
BFKO4P
BFKO4P
Dalton transactions (Cambridge, England : 2003) (2017) 46, 5 1677-1683
a=4.2917(9)Å b=7.8624(15)Å c=12.0505(19)Å
α=90° β=90.44(3)° γ=90°
C50H60Cl6Cr2N2O2
C50H60Cl6Cr2N2O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 34 8643-8650
a=16.312(4)Å b=12.288(4)Å c=29.792(6)Å
α=90.00° β=120.392(10)° γ=90.00°
C66H76Cl2Cr2N2O2
C66H76Cl2Cr2N2O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 34 8643-8650
a=18.076(5)Å b=18.047(5)Å c=23.103(4)Å
α=90.00° β=125.714(14)° γ=90.00°
C47H53ClCrNO2
C47H53ClCrNO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 34 8643-8650
a=11.6666(16)Å b=20.495(3)Å c=17.050(2)Å
α=90.00° β=92.581(2)° γ=90.00°
C16H64Ce2N16Se8Sn2
C16H64Ce2N16Se8Sn2
Dalton Transactions (2011) 40, 11 2631
a=10.0942(10)Å b=16.6159(13)Å c=13.3973(13)Å
α=90.00° β=101.878(3)° γ=90.00°
C12H50N12O2Pr2Se6Sn2
C12H50N12O2Pr2Se6Sn2
Dalton Transactions (2011) 40, 11 2631
a=10.1968(11)Å b=11.7622(9)Å c=15.4969(16)Å
α=90.00° β=98.967(3)° γ=90.00°
C12H50N12Nd2O2Se6Sn2
C12H50N12Nd2O2Se6Sn2
Dalton Transactions (2011) 40, 11 2631
a=10.1764(18)Å b=11.7725(19)Å c=15.470(3)Å
α=90.00° β=99.128(4)° γ=90.00°
C12H50Gd2N12O2Se6Sn2
C12H50Gd2N12O2Se6Sn2
Dalton Transactions (2011) 40, 11 2631
a=9.9927(13)Å b=11.8421(15)Å c=15.313(2)Å
α=90.00° β=99.979(3)° γ=90.00°
C32H104Ce4N24Se15Sn4
C32H104Ce4N24Se15Sn4
Dalton Transactions (2011) 40, 11 2631
a=10.2333(6)Å b=13.0790(9)Å c=15.7663(9)Å
α=80.422(4)° β=73.738(3)° γ=88.376(4)°
C32H104N24Nd4Se15Sn4
C32H104N24Nd4Se15Sn4
Dalton Transactions (2011) 40, 11 2631
a=10.1844(11)Å b=12.9795(17)Å c=15.7510(16)Å
α=80.448(6)° β=73.991(6)° γ=88.552(7)°
C12H40GdN9Se4Sn
C12H40GdN9Se4Sn
Dalton Transactions (2011) 40, 11 2631
a=10.3004(15)Å b=9.4257(11)Å c=13.875(2)Å
α=90.00° β=101.678(4)° γ=90.00°
C6H26AsN6NdOSe4
C6H26AsN6NdOSe4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=9.4580(16)Å b=13.545(3)Å c=14.948(3)Å
α=90.00° β=90.00° γ=90.00°
C9H36AsN9Se4Sm
C9H36AsN9Se4Sm
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=11.1989(17)Å b=12.9457(19)Å c=16.241(3)Å
α=90.00° β=92.360(3)° γ=90.00°
C9H36AsGdN9Se4
C9H36AsGdN9Se4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=11.2363(4)Å b=12.9565(4)Å c=16.2341(6)Å
α=90.00° β=92.235(2)° γ=90.00°
C9H36AsDyN9Se4
C9H36AsDyN9Se4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=11.239(2)Å b=12.952(3)Å c=16.241(3)Å
α=90.00° β=92.262(4)° γ=90.00°
C8H26AsLaN6Se4
C8H26AsLaN6Se4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=8.8148(12)Å b=16.607(2)Å c=26.767(4)Å
α=90.00° β=90.00° γ=90.00°
C8H26AsCeN6Se4
C8H26AsCeN6Se4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=8.8021(9)Å b=16.5022(14)Å c=26.691(3)Å
α=90.00° β=90.00° γ=90.00°
C8H26AsN6PrSe4
C8H26AsN6PrSe4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=8.8169(13)Å b=16.489(3)Å c=26.719(4)Å
α=90.00° β=90.00° γ=90.00°
C8H26AsLaN6Se4
C8H26AsLaN6Se4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=8.7554(15)Å b=11.3211(18)Å c=19.807(4)Å
α=90.00° β=90.00° γ=90.00°
C8H26AsN6NdSe4
C8H26AsN6NdSe4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=8.746(2)Å b=11.277(3)Å c=19.717(6)Å
α=90.00° β=90.00° γ=90.00°
C8H26AsN6Se4Sm
C8H26AsN6Se4Sm
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=10.009(2)Å b=13.427(2)Å c=14.821(3)Å
α=90.00° β=98.201(7)° γ=90.00°
C6H26AsCeN6OSe4
C6H26AsCeN6OSe4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=19.073(3)Å b=19.073(3)Å c=9.4673(14)Å
α=90.00° β=90.00° γ=120.00°
C6H26AsLaN6OSe4
C6H26AsLaN6OSe4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 30 7066-7072
a=19.112(2)Å b=19.112(2)Å c=9.4870(10)Å
α=90.00° β=90.00° γ=120.00°
C20H22CaO14,H1.20O0.60,2(H2O),0.8(H2O),0.6(H2O)
C20H22CaO14,H1.20O0.60,2(H2O),0.8(H2O),0.6(H2O)
Chemical communications (Cambridge, England) (2007) 42 4416-4418
a=28.071(5)Å b=17.472(5)Å c=6.2294(13)Å
α=90.00° β=97.557(5)° γ=90.00°
C11H12O5
C11H12O5
Chem.Commun. (2012) 48, 12080
a=20.4479(17)Å b=3.9674(3)Å c=13.2324(12)Å
α=90.00° β=90.00° γ=90.00°
C68H105N9O10S
C68H105N9O10S
Chemical communications (Cambridge, England) (2013) 49, 20 2025-2027
a=12.9919(11)Å b=14.4679(12)Å c=19.3290(13)Å
α=94.8590(10)° β=96.631(2)° γ=94.2570(10)°
C33H27BrN2O3
C33H27BrN2O3
Chem.Commun. (2012) 48, 5124
a=11.654(11)Å b=8.990(8)Å c=14.054(13)Å
α=90.00° β=108.273(17)° γ=90.00°
2(C22H28N8NiO8),5(H2O)
2(C22H28N8NiO8),5(H2O)
Chemical communications (Cambridge, England) (2007) 22 2293-2295
a=12.5611(4)Å b=12.5611(4)Å c=62.471(3)Å
α=90.00° β=90.00° γ=120.00°
2(C22H28CoN8O8),5(H2O)
2(C22H28CoN8O8),5(H2O)
Chemical communications (Cambridge, England) (2007) 22 2293-2295
a=12.5764(6)Å b=12.5764(6)Å c=62.941(4)Å
α=90.00° β=90.00° γ=120.00°
C45H60N2PScSi
C45H60N2PScSi
Chem.Commun. (2012) 48, 7516
a=12.1570(15)Å b=12.3456(15)Å c=15.2613(19)Å
α=84.741(2)° β=77.710(2)° γ=72.545(2)°
C55H68N6PSc
C55H68N6PSc
Chem.Commun. (2012) 48, 7516
a=9.9885(5)Å b=17.1263(9)Å c=17.6568(9)Å
α=79.8850(10)° β=82.1400(10)° γ=79.1570(10)°
C15H12Mo2N3NiO7
C15H12Mo2N3NiO7
RSC Advances (2014) 4, 53 27787
a=7.1747(5)Å b=11.1258(13)Å c=11.4017(8)Å
α=98.021(8)° β=90.098(6)° γ=106.227(8)°
C17H20N2OS3
C17H20N2OS3
RSC Adv. (2014)
a=8.2731(4)Å b=10.7452(5)Å c=20.7803(10)Å
α=90.00° β=90.00° γ=90.00°
C24H16Ag6K2N20O40PW12
C24H16Ag6K2N20O40PW12
CrystEngComm (2013) 15, 48 10584
a=10.5554(8)Å b=22.6863(18)Å c=12.4204(10)Å
α=90.00° β=100.7120(10)° γ=90.00°
C26H26ClF3N3O4RhS
C26H26ClF3N3O4RhS
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12221-12227
a=8.583(4)Å b=16.929(7)Å c=19.659(8)Å
α=90.00° β=99.892(5)° γ=90.00°
C27H27F6N3O8RhS2
C27H27F6N3O8RhS2
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12221-12227
a=9.1279(17)Å b=11.394(2)Å c=16.825(3)Å
α=102.330(3)° β=96.882(2)° γ=104.537(2)°
F12GeH21.62K2.79Mn6Na8O41.21P8
F12GeH21.62K2.79Mn6Na8O41.21P8
Dalton transactions (Cambridge, England : 2003) (2015) 44, 17 7960-7966
a=15.981(7)Å b=15.981(7)Å c=15.981(7)Å
α=90° β=90° γ=90°
F12H18.78K3.74Mn7Na8O40.26P8
F12H18.78K3.74Mn7Na8O40.26P8
Dalton transactions (Cambridge, England : 2003) (2015) 44, 17 7960-7966
a=15.968(2)Å b=15.968(2)Å c=15.968(2)Å
α=90° β=90° γ=90°
F12H21.1K2.97Mn6Na8O41.03P8Ti
F12H21.1K2.97Mn6Na8O41.03P8Ti
Dalton transactions (Cambridge, England : 2003) (2015) 44, 17 7960-7966
a=16.0001(2)Å b=16.0001(2)Å c=16.0001(2)Å
α=90° β=90° γ=90°
C25H49ClN3OP2Rh
C25H49ClN3OP2Rh
Dalton transactions (Cambridge, England : 2003) (2015) 44, 34 15111-15115
a=15.4568(12)Å b=15.5903(8)Å c=16.3952(11)Å
α=90.00° β=90.00° γ=90.00°
C22H40N3OP2Rh
C22H40N3OP2Rh
Dalton transactions (Cambridge, England : 2003) (2015) 44, 34 15111-15115
a=22.5273(4)Å b=8.11695(15)Å c=14.1994(2)Å
α=90.00° β=90.00° γ=90.00°
C25H46N3O7P2Rh
C25H46N3O7P2Rh
Dalton transactions (Cambridge, England : 2003) (2015) 44, 34 15111-15115
a=8.15073(17)Å b=23.7055(6)Å c=8.4853(2)Å
α=90.00° β=100.062(2)° γ=90.00°
Hydroxylethylammonium enrofloxacinate
C2H8NO,C19H21FN3O3
Acta Crystallographica Section E (2004) 60, 10 o1694-o1696
a=9.791(2)Å b=9.8580(10)Å c=12.274(2)Å
α=69.120(10)° β=75.740(10)° γ=89.540(10)°
(R,R)-N,N'-Bis(5-chloro-salicylidene)-1,2-cyclohexanediamine
C20H20Cl2N2O2
Acta Crystallographica Section E (2004) 60, 12 o2397-o2398
a=18.990(6)Å b=5.829(2)Å c=8.839(3)Å
α=90.00° β=90.00° γ=90.00°
4-(o-Methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2H-pyrano[2,3-d]pyrimidin- 2-thione
C14H18N2O2S
Acta Crystallographica Section E (2005) 61, 5 o1228-o1230
a=8.5277(8)Å b=14.2285(13)Å c=11.5972(11)Å
α=90.00° β=93.590(2)° γ=90.00°
Methyl 12-benzoyldehydroabietate
C28H34O3
Acta Crystallographica Section E (2006) 62, 5 o1895-o1897
a=14.0617(13)Å b=6.0363(5)Å c=28.051(4)Å
α=90.00° β=102.40(2)° γ=90.00°
(+)-6-Amino-2-(2-thienyl)-1,4-thiazepan-5-one
C9H12N2OS2
Acta Crystallographica Section E (2006) 62, 6 o2337-o2338
a=6.314(3)Å b=9.785(3)Å c=17.289(6)Å
α=90.0000° β=90.0000° γ=90.0000°
C15H17FO
C15H17FO
Acta Crystallographica Section E (2004) 60, 6 o1000-o1002
a=12.2910(10)Å b=8.2940(10)Å c=12.2730(10)Å
α=90.00° β=90.00° γ=90.00°
(E)-1-[1-ethoxycarbonyl-2(N-benzylamino)-1-propenyl]benzotriazole.
C19H20N4O2
Acta Crystallographica Section E (2004) 60, 6 o1021-o1022
a=13.071(3)Å b=8.3600(10)Å c=17.418(4)Å
α=90° β=109.01(2)° γ=90°
6α-Hydroxy-12-oleanen-3-one
C30H48O2
Acta Crystallographica Section E (2005) 61, 7 o2022-o2023
a=11.5254(14)Å b=14.5357(18)Å c=15.769(2)Å
α=90.00° β=90.00° γ=90.00°
Methyl {2-[4-ethyl-1-(tolylsulfonyl)-2,3-dihydropyrrol-3-yl]ethyl}benzoate
C23H27NO4S
Acta Crystallographica Section E (2003) 59, 10 o1578-o1580
a=8.412(2)Å b=10.931(2)Å c=11.989(2)Å
α=83.730(10)° β=81.300(10)° γ=80.320(10)°
Alisol B monoacetate
C32H50O5
Acta Crystallographica Section E (2003) 59, 11 o1858-o1859
a=7.7160(10)Å b=14.495(2)Å c=27.526(5)Å
α=90.00° β=90.00° γ=90.00°
C10H17N2O1,H2O4P1
C10H17N2O1,H2O4P1
Acta Crystallographica Section E (2005) 61, 2 o413-o415
a=8.3212(8)Å b=8.9609(9)Å c=9.8813(10)Å
α=97.070(2)° β=101.475(2)° γ=108.355(2)°
C33H48ClNO9
C33H48ClNO9
Acta Crystallographica Section E (2004) 60, 10 o1905-o1906
a=10.9898(4)Å b=15.7406(7)Å c=20.7781(6)Å
α=90° β=90° γ=90°
C33H49NO10
C33H49NO10
Acta Crystallographica Section E (2004) 60, 11 o1959-o1960
a=11.1774(8)Å b=11.2461(8)Å c=29.072(2)Å
α=90.00° β=90.00° γ=90.00°
(S)-(-)-5,5'-Bis(diphenylphosphino)-2,2,2',2'-tetramethyl-4,4'-bi- 1,3-benzodioxole
C42H36O4P2
Acta Crystallographica Section E (2004) 60, 11 o2133-o2134
a=9.7007(9)Å b=20.774(2)Å c=8.9149(9)Å
α=90.00° β=90.00° γ=90.00°
2-{[(2-Hydroxyphenyl)methyl]methylamino}-1-phenylpropan-1-ol
C17H21NO2
Acta Crystallographica Section E (2003) 59, 5 o608-o609
a=6.0040(10)Å b=10.4510(10)Å c=23.790(3)Å
α=90.00° β=90.00° γ=90.00°
3-Ethyl-1-(4-methylphenylsulfonyl)-4-phenethyl-4,5-dihydropyrrole
C21H25NO2S
Acta Crystallographica Section E (2003) 59, 11 o1636-o1637
a=8.250(2)Å b=10.740(2)Å c=12.020(2)Å
α=66.05(3)° β=76.82(3)° γ=81.95(3)°
6-ethenyldecahydro-5-hydroxy-4,6,9,10-tetramethyl-1-oxo- 3a,9-propano-3aH-cyclopentacycloocten-8-yl [2-(diethylammonio)ethylsulfanyl]acetate (E)-3-carboxyprop-2-enoate methanol solvate
C28H48NO4S,C4H3O4,CH4O
Acta Crystallographica Section E (2004) 60, 9 o1546-o1548
a=9.9350(10)Å b=10.0720(10)Å c=34.987(7)Å
α=90.00° β=90.00° γ=90.00°
(E)-2-(4-Chlorobenzylidene)cyclooctanone
C15H17ClO
Acta Crystallographica Section E (2004) 60, 9 o1504-o1506
a=7.4740(10)Å b=10.5450(10)Å c=8.5680(10)Å
α=90.00° β=100.223(9)° γ=90.00°
Methyl 12-bromo-13,14-dinitrodeisopropyldehydroabietate
C18H21BrN2O6
Acta Crystallographica Section E (2005) 61, 9 o3003-o3005
a=10.215(5)Å b=11.003(5)Å c=16.761(7)Å
α=90.00° β=90.00° γ=90.00°
(4aR,6bR,12aR)-10-Hydroxy-2,2,4a,6b,9,9,12a-heptamethyl- 2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro- 1H-picene-6a-carboxylic acid methanol solvate
C30H48O3,CH4O
Acta Crystallographica Section E (2003) 59, 7 o989-o991
a=7.538(2)Å b=13.710(3)Å c=27.629(8)Å
α=90.00° β=90.00° γ=90.00°
(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxy-N-methyl-1-hexanaminium-2- [2-methyl-3-(trifluoromethyl)anilino]nicotinate
C7H18NO51,C14H10F3N2O21
Acta Crystallographica Section E (2003) 59, 10 o1471-o1473
a=9.9100(10)Å b=6.9140(10)Å c=16.578(2)Å
α=90.00° β=91.860(10)° γ=90.00°
4-p-Tolyl-1,3,4,4a,5,6,7,8a-octahydro-2H-pyrano[2,3-d]pyrimidin-2-one
C14H18N2O2
Acta Crystallographica Section E (2005) 61, 4 o1049-o1051
a=7.7151(10)Å b=8.5541(11)Å c=9.6887(13)Å
α=88.516(2)° β=76.964(2)° γ=83.401(2)°
9-Butyl-3,4,5,6,7,9-hexahydro-2H-xanthene-1,8-dione
C17H22O3
Acta Crystallographica Section E (2005) 61, 4 o1139-o1140
a=15.121(4)Å b=8.872(2)Å c=11.025(3)Å
α=90.00° β=90.00° γ=90.00°
Dimethyl[4-methyl-2,6-bis(phenyliminomethyl)phenolato-κ^2^N,O]gallium(III)
C23H23GaN2O
Acta Crystallographica Section E (2005) 61, 4 m614-m615
a=9.4980(10)Å b=13.0280(10)Å c=16.598(2)Å
α=90.00° β=95.040(10)° γ=90.00°
Risperidone chloride 2.5-hydrate
C23H28F1N4O2,Cl,2.5H2O1
Acta Crystallographica Section E (2006) 62, 2 o768-o770
a=10.027(3)Å b=18.431(4)Å c=13.394(4)Å
α=90.0000° β=100.613(11)° γ=90.0000°
C22H24InOP
C22H24InOP
Acta Crystallographica Section C (1996) 52, 7 1661-1663
a=9.089(2)Å b=9.418(3)Å c=12.575(8)Å
α=89.45(4)° β=105.25(3)° γ=91.85(2)°
C14H25AlN2
C14H25AlN2
Acta Crystallographica Section C (1996) 52, 3 607-609
a=10.130(5)Å b=9.107(2)Å c=17.620(4)Å
α=90.° β=106.57(3)° γ=90.°
1,4-bis(trimethylindium)-1,4-dibenzylpiperazine
C36H52In2N2
Acta Crystallographica Section C (1997) 53, 3 278-279
a=9.543(4)Å b=10.176(2)Å c=11.340(3)Å
α=84.56(2)° β=113.62(3)° γ=114.04(2)°
C16H22ClNO4
C16H22ClNO4
Acta Crystallographica Section C (1994) 50, 4 609-613
a=8.427(2)Å b=13.5090(10)Å c=7.467(3)Å
α=92.06(2)° β=111.18(2)° γ=94.110(10)°
C17H24Cl3N
C17H24Cl3N
Acta Crystallographica Section C (1994) 50, 4 609-613
a=10.597(3)Å b=11.704(4)Å c=14.390(6)Å
α=90.° β=103.28(3)° γ=90.°
Trimethyl[9-(dimethylaminomethyl)carbazole]gallium
C18H25GaN2
Acta Crystallographica Section C (1997) 53, 2 190-191
a=11.932(2)Å b=10.032(8)Å c=15.309(3)Å
α=90.° β=109.73(1)° γ=90.°
C8H17ClCuN6O4S
C8H17ClCuN6O4S
Acta Crystallographica Section C (1997) 53, 3 276-278
a=13.735(3)Å b=16.082(6)Å c=14.255(4)Å
α=90.° β=90.° γ=90.°
Diaquabis(quinoline-8-sulfonato-κ^2^N,O)zinc(II)
C18H16N2O8S2Zn
Acta Crystallographica Section E (2006) 62, 11 m2970-m2971
a=8.580(5)Å b=15.037(5)Å c=7.798(5)Å
α=90.000° β=113.038(5)° γ=90.000°
Catena-Poly[[[tetraaquacadmium(II)]-μ-4,4-bipyridine-κ^2^N:N'] benzene-1,4-dicarboxylate]
C10H16CdN2O42,C8H4O42
Acta Crystallographica Section E (2006) 62, 11 m3034-m3035
a=7.029(5)Å b=11.649(5)Å c=11.541(5)Å
α=90.00° β=102.143(5)° γ=90.00°
Diethyl 2,3-O-benzylidene-D-tartarate
C15H18O6
Acta Crystallographica Section E (2007) 63, 3 o1093-o1094
a=7.5400(15)Å b=26.500(5)Å c=8.2100(16)Å
α=90.00° β=114.50(3)° γ=90.00°
Perhydrophthalimide
C8H11NO2
Acta Crystallographica Section E (2007) 63, 10 o3990-o3990
a=6.7574(12)Å b=7.8615(14)Å c=14.371(3)Å
α=90.00° β=90.00° γ=90.00°
Catena-Poly[[[tetraaquacadmium(II)]-μ-4,4-bipyridine] fumarate tetrahydrate]
C10H16CdN2O4,2(C2HO2),4(H2O)
Acta Crystallographica Section E (2008) 64, 1 m192-m193
a=7.183(5)Å b=7.802(5)Å c=10.038(5)Å
α=80.434(5)° β=87.791(5)° γ=73.288(5)°
Bis[μ-4-amino-3,5-bis(hydroxymethyl)-1,2,4-triazole]bis{bis[4-amino-3,5- bis(hydroxymethyl)-1,2,4-triazole]nickel(II)} tetranitrate methanol disolvate
C24H48N26Ni2O182,4(NO3),2(CH4O)
Acta Crystallographica Section E (2008) 64, 1 m96-m97
a=12.5126(17)Å b=13.2808(18)Å c=16.153(2)Å
α=90.00° β=92.699(2)° γ=90.00°
Methyl cis-deisopropyldehydroabietate
C18H24O2
Acta Crystallographica Section E (2006) 62, 8 o3166-o3167
a=8.459(2)Å b=7.4681(19)Å c=11.701(3)Å
α=90.00° β=95.173(5)° γ=90.00°
Bis(μ~2~-(3-methylbut-2-enoato-κ^2^O:O)bis{[(2- methoxyphenyl)diphenylphosphine-κP]silver(I)}
C48H48Ag2O6P2
Acta Crystallographica Section E (2007) 63, 4 m1068-m1069
a=8.6740(17)Å b=16.500(3)Å c=16.365(3)Å
α=90.00° β=105.09(3)° γ=90.00°
Bis(pyridine-2-methanol-κ^2^<i>N</i>,<i>O</i>]bis(thiocyanato-κN)cobalt(II)
C14H14CoN4O2S2
Acta Crystallographica Section E (2007) 63, 12 m3034-m3034
a=11.371(10)Å b=8.255(8)Å c=17.779(16)Å
α=90.00° β=90.00° γ=90.00°
Methyl 12-chlorodehydroabietate
C21H29ClO2
Acta Crystallographica Section E (2006) 62, 12 o5425-o5426
a=13.6507(17)Å b=6.0856(6)Å c=23.120(3)Å
α=90.00° β=102.760(16)° γ=90.00°
Maleopimaric acid trimethyl ester
C27H40O6
Acta Crystallographica Section E (2006) 62, 12 o5701-o5703
a=8.9848(15)Å b=23.456(4)Å c=12.364(2)Å
α=90.00° β=108.804(3)° γ=90.00°
1,3,8-Trihydroxy-6-methylanthraquinone monohydrate
C15H10O5,H2O
Acta Crystallographica Section E (2007) 63, 1 o233-o235
a=9.570(3)Å b=15.142(3)Å c=9.245(3)Å
α=90.00° β=113.140(6)° γ=90.00°
(E)-3-Bromo-N-(1,3-oxazolidin-2-ylidene)benzamide
C10H9BrN2O2
Acta Crystallographica Section E (2008) 64, 1 o106-o106
a=8.3877(9)Å b=12.5593(14)Å c=10.1907(12)Å
α=90° β=107.222(2)° γ=90°
<i>N</i>-(2-Chloro-2-nitro-1-phenylpropyl)-4-methylbenzenesulfonamide
C16H17ClN2O4S
Acta Crystallographica Section E (2008) 64, 2 o357-o357
a=7.8254(8)Å b=19.610(2)Å c=22.533(3)Å
α=90.00° β=90.00° γ=90.00°
3β,6β-dihydroxy-olean-12-en-27-oic acid
C30H48O4
Acta Crystallographica Section C (2004) 60, 4 o300-o302
a=12.016(2)Å b=14.141(2)Å c=15.406(2)Å
α=90.00° β=90.00° γ=90.00°
Sodium vanadium dioxide difluoride
F2O2V,Na
Acta Crystallographica Section C (2015) 71, 6
a=6.3846(18)Å b=3.6024(9)Å c=14.387(4)Å
α=90° β=110.636(10)° γ=90°
Sodium vanadium dioxide difluoride
F2O2V,Na
Acta Crystallographica Section C (2015) 71, 6
a=6.400(5)Å b=3.614(2)Å c=14.453(12)Å
α=90° β=110.369(10)° γ=90°
Sodium vanadium dioxide difluoride
F2NaO2V
Acta Crystallographica Section C (2015) 71, 6
a=6.369(5)Å b=3.625(2)Å c=7.196(6)Å
α=90° β=110.37(4)° γ=90°
Adamantane-1,3-dicarboxylic acid--4,4'-bipyridine (1/1)
C12H16O4,C10H8N2
Acta Crystallographica Section C (2008) 64, 2 o41-o43
a=21.5610(16)Å b=7.2378(5)Å c=12.1520(9)Å
α=90.00° β=92.5800(10)° γ=90.00°
Bis(2-hydroxy-<i>N</i>-isopropylidenebenzohydrazidato- κ^2^<i>N</i>',<i>O</i>)bis(pyridine-κ<i>N</i>)cobalt(II)
C30H32CoN6O4
Acta Crystallographica Section E (2009) 65, 4 m457-m458
a=7.7751(9)Å b=10.0168(15)Å c=18.751(2)Å
α=90.00° β=96.621(2)° γ=90.00°
Triaquachlorido(1,10-phenanthroline-κ^2^N,<i>N</i>)cobalt(II) chloride monohydrate
C12H14Cl1CoN2O3,Cl,H2O
Acta Crystallographica Section E (2009) 65, 1 m114
a=7.646(4)Å b=12.426(6)Å c=16.987(8)Å
α=90.00° β=103.54(2)° γ=90.00°
Sodium calcium arsenate
AsCaNaO4
Acta Crystallographica Section E (2011) 67, 12 i69
a=11.486(2)Å b=6.6615(14)Å c=5.2406(11)Å
α=90.00° β=90.00° γ=90.00°
<i>trans</i>-Dichloridobis(2,4-dimethylaniline-κ<i>N</i>)palladium(II)
C16H22Cl2N2Pd
Acta Crystallographica Section E (2012) 68, 5 m592
a=14.315(6)Å b=8.081(3)Å c=7.420(3)Å
α=90.00° β=104.705(7)° γ=90.00°
(<i>E</i>)-<i>N</i>-(2,4-Dichlorobenzylidene)-2,5-dimethoxyaniline
C15H13Cl2NO2
Acta Crystallographica Section E (2013) 69, 4 o469
a=13.2879(12)Å b=5.1329(5)Å c=21.1490(18)Å
α=90.00° β=96.622(2)° γ=90.00°
C360O91Zn28
C360O91Zn28
Chemistry of Materials (2020)
a=42.4115(7)Å b=42.4115(7)Å c=42.4115(7)Å
α=90° β=90° γ=90°